Pelthos Therapeutics PTHS Ratios (2024-2026)

NYSE PTHS
$26.53 +0.69 (+2.67%)
At close: Aug 20, 2026 · 4:00 PM EDT
Ratios Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Profitability
Gross Margin (Quarter) -687.76%89.87%80.07%
EBT Margin (Quarter) -5,681.29%-173.24%-182.92%
EBIT Margin (Quarter) -5,225.17%-72.74%-114.72%
EBITDA Margin (Quarter) -5,225.17%-72.74%-114.72%
Operating Margin (Quarter) -5,225.17%-72.74%-114.72%
Net Margin (Quarter) -5,523.13%-131.29%-182.92%
FCF Margin (Quarter) -5,190.04%-37.89%-79.17%
Efficiency
Inventory Average (Quarter) 23.84M22.52M
Assets Average (Quarter) 2.06M3.32M2.37M1.75M1.14M0.87M63.63M128.41M133.88M
Invested Capital (Quarter) 0.13M
Asset Utilization Ratio (Quarter) 0.32
Leverage & Solvency
Interest Coverage Ratio (Quarter) -6.41
Debt Ratio (Quarter) 0.19
Times Interest Earned (Quarter) -6.41
Valuation
Enterprise Value (Quarter) -24.56M
Return Ratios
Return on Sales (Quarter) -0.02%
Return on Capital Employed (Quarter) -59.86%
Return on Assets (Quarter) -0.01%